Introduction
Cystatin C, alias post-y-globulin or -trace protein is a protein which is present in low concentration in human body fluids, especially in the cerebrospinal fluid (CSF) (l, 2, 3). It has also been shown to be localized in the cytoplasma of cells, in the adenohypophysis (4), in the adrenal medulla (5) and in the A-cells of the Langerhans islets of the pancreas (6) . The exact biological role of -trace protein is äs yet unknown, but Löfberg & Grubb (2) have proposed that it could be associated with the neuroendocrine System; recently Barren et al. (7) have shown post-y-glpbuliii to be a potent inhibitor of the cysteine proteinases papain, ficin, and human cathepsins B, H, and L.
They proposed the name cystatin C for post-y-globulin and suggested that its physiological function could well be the regulation of proteinase activity.
When routinely assaying CSF from patients with multiple sclerosis by agar gel electrophoresis, we frequently observed no cystatin C at all or very low relative values, in contrast to controls.
Using radial immunodiffusion, we investigated the cystatin C content of CSF from patients affected with multiple sclerosis, a group of patients with various neurological diseases and control CSF; we also determined cystatin C in brain specimens from 2 multiple sclerosis patients and 3 control brains.
The purpose was to confirm our earlier electrophoretic observations and to determine whether cystatin C can be considered äs a marker for multiple sclerosis and demyelination.
Materials and Methods
Cerebrospinal fluids -Control CSF were obtained from patients either without or with minor neurological signs, or minor psychotic disturbances (n = 25). These samples were considered normal by routine äs well äs by electrophoretic examination. Age ränge: 16-74years.
Patients aftected with neurological diseases other than confirmed multiple sclerosis (n = 22) were selected on the basis of thc clinical course of the disease, routine examination of the CSF and agar gel electrophoresis (tab. 1). Age ränge: 22-85 years.
Patients affected with clinically confirmed multiple sclerosis (n = 31) were considered; the criteria used to establish the diagnosis were the following: clinical multifocal lesions of the CNS, the typical clinical evolution of the disease, routine examination of the CSF and agar gel electrophoresis. Age ränge: 14-72 years.
No sex differentiation was made for any of the groups linder investigation. All CSF samples were stored at -20 °C and thawed once; prior to assay by agar gel electrophoresis, CSF samples were concentrated on ultrafiltration membranes with a 10000 molecular weight cut off (Sartorius SM 145.39.025 N).
Brain tissue
Whole white and gray matter was obtained from patients with clinically confirmed multiple sclerosis; the diagnosis was established äs for the CSF sample patients and confirmed by the presence of plaques in the post-mortem brain.
Multiple sclerosis brains were stored at -70 °C for several years (1-4 ^ears) before extraction. Control brains were obtained from patients who were not affected with neurological diseases and whose brain appeared normal at dissection. Those brains were extracted immediately after autopsy.
For all brain specimens under investigation the delay between death and autopsy did not exceed 24 h.
Brain extraction
The brain specimens (50% w/v homogenate) were homogenized in 0.01 mol/1 phosphate -0.15 mol/1 NaCl -pH 7. 
Statistics
Since a normal distribution cannot be assurned in pathological states, the statistical methöd used to cornpare the different populations was the non parametric U-test of Wflcoxon*).
The existence or non-e^istence of correlations between the chosen variables was determined qualitatively by scatter diagrams äs reported by Spiegel (8) .
Results
Figure l shows the cystatin C Contents of all groups under investigation. Controls gave a median value of 11.4 mg/1 and a ränge of 4.6 -31.2 mg/1. The group of other neurological patients was charäctefized by some decreased cystatin C values, but on the whole the median value (10.2 mg/1) was very near the control one.
In the multiple sclerosis group many cystatin C values were either zero or considerably decreased in compar ison with the controls. The median values and signiflcant differences between the control group and pathological groups are reported in table 2. Multiple sclerosis differs significantly from controls and other neurological diseases, but there are no significant differences between controls and other neurological diseases.
A possible correlation between the age of the patients and the cystatin C content was investigated but none could be established.
When assaying brain specimens at the total protein concentration of 0.3 g/l (CSF mean value) no cystatin C could be detected; it was necessary to concentrate the brain specimens up to a total protein concentration of 50.0 g/l to obtain a position answer (tab. 3). This means that the cystatin C levels of both normal and pathologic brains are exceedingly low, and consequently hardly detectable, s is the case for serum. 
Biscussion
In 1965 Mac Pherson (9) first reported a quantitative estimation of cystatin C, formerly post-y-globulin, in normal and pathological CSR She found a general decrease of cystatin C in patients affected with multiple sclerosis; this finding was confirmed by Pepe et al. (10) . Löfberg et al. (11) however, found no sigüifi-cant decrease in the concentration of -trace in CSF in the multiple sclerosis group. As a general rule they observed that the concentration of -trace in CSF was slightly increased in individuals older than 60 years. In contrast to Löfberg et al., but in agreement with Mac Pherson, we found a significant decrease oftrace in the multiple sclerosis group, when we investigated numerically much larger groups. For multiple sclerosis patients and neurological patients with disorders other than multiple sclerosis, Mac Pherson reported mean values of 7.1 mg/1 and 9.8 mg/1, respectively, whereas we found median values of 7.2 mg/1 and 10.2 nig/1. Contrary to earlier fmdings (11) , no correlation was found between patient age and the cystatin C content.
The primary site of cystatin C is not known with certainty, due to the wide organ distribution of the protein.
According to Mac Pherson (9) transsudation of cystatin C from the blood to the CSF is to be excluded, since there are rarely detectable levels in normal human serum, compared with CSF. It is a fact that cystatin C concentrations are much higher in CSF than in serum (3): when we concentrated serum 20 times, cystatin C could still not be detected by radial immunodiffusion, whereas the technique works very well for unconcentrated CSF.
Hochwald et al. (12) demonstrated in monkeys that many tissues incorporate labeled amino acids into cystatin C; submaxillary gland seemed to be the most active; brain cultures were negative, but the choroid plexus did produce some degree of cystatin labelling. From their study they derived the hypothesis that this protein is transported to the CSF by blood. However since the choroid plexus produces a large part of the CSF, this could be a likely source of cystatin C.
Our determined cystatin C contents in human brain material (tab. 3) do not Support the notion that this protein is produced in the CNS. Consequently the cystatin C of the CSF cannot be derived from brain cystatin C; it seems more likely that cystatin C diffuses from the CSF to the CNS in very small amounts. But it is difficult to consider these results äs significant, since the brain specimens had to be "super-concentrated," in order to find any positive results at all.
Abnormal cystatin C levels are interesting in view of the possible biological role of this protein. Given that this protein has been found in many tissues, but in very low concentrations in normal serum, it could be that cystatin C is an intracellular inhibitor of cysteine proteinases. Since cysteine proteinases are abundant in the body and are responsible for much of the intracellular proteolysis (13) , the role of cystatins could be vital in limiting proteolysis. At least one type of cystatin, namely from chicken egg white, has been demonstrated to be an inhibitor of cysteine proteinases (14) .
Recently, studies haVe been reported on human cystatin from the serum of patients affected with autoî mmune diseases (15) . From the biochemical data (relative molecular mass, amirio acid cornposition, amino acid sequence, isoelectric focusing) it was coaclüded that this protein was practically identical to human post-y-globulin, a protein of hithertp unkriöwn function.
Barren et al. (7), äs mentioned above, suggested that the physiological role of this protein may well be the local regulation of cysteine proteinases, which pass from the lysosomal System to extracellular fluid, and also to the cytoplasm in some cells. Indeedj many cathepsins are associated with lysosomal like particles and are believed to participate in mechanisms of protein breakdown or are released into the cytoplasm to participate in the turnover of cellular components. If demyelination is caused by one or more intracellular proteases, then Inhibition of these enzyme activities could offer the possibility of limiting the extent of demyelination. In multiple sclerosis the regulation of cysteine proteinases seems to be impaired; indeed most cystatin C values in CSF were either zero or depressed.
One may speculate 1. that the very low Inhibition levels in the CSF of multiple sclerosis patients are due to a decreased release of inhibitor from cells, whieh in turn is a result of the underlying immunological process in this disease; and 2. that the activity of the CSF may make a significant contribution to pathological processes, such äs demyelination, which occur in the CNS.
Another mechanism could be the role of macrophages during the effector phase of demyelination. Because of the predpminance of macrophages in lesions of inflammatory demyelinating diseases such äs multiple sclerosis, it has been suggested that such cells may be involved in degradation of myelin; indeed, degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages has been demonstrated by Cammer et al. (16) .
Certain cysteine proteinases (for example cathepsin B) are synthesized by macrophages and the balance between inhibited cysteine proteinase-associated macrophages and active cysteine proteinase-associated macrophages is most probably impaired by the decrease of cystatin C; this impaired balance may induce demyelination.
The absence or low level of cystatin C is especially marked in multiple sclerosis, an inflammatory demyelinating disease. In the non demyelinating inflammatory diseases in the patients group with other neurological diseases (tab. l, fig. 1 ) it is obvious that the cystatin C values score mainly in the control ränge.
Consequently, although it is perhaps a little premature to consider cystatin C äs a marker for multiple sclerosis, this protein is nevertheless associated with demyelination.
In our opinion its routine biochemical assay can be considered äs a complementary diagnostic tool.
